If You'd Invested $1,000 in QQQ 20 Years Ago, Here's What You'd Have Today Your investment would have grown substantially, but only if you exercised discipline and patience.
Better Growth Stock ETF: Vanguard's Large-Cap VUG vs. Invesco's Small-Cap RZG VUG delivered 80% higher five-year returns despite a 10x higher expense ratio, but RZG surged 26.9% over the past year.
What I Learned From Investing Through 3 Big Stock Market Crashes The stock market has recovered from the biggest crashes. Crises end, but the world keeps going.
Which Healthcare ETF Offers the Better Growth Outlook: VanEck Biotech or Invesco Pharmaceuticals? VanEck focuses on a clutch of biotech leaders with lower fees; Invesco tracks a select group of pharma companies with higher dividend yield and stronger five-year returns.
If I Could Invest in Just 1 ETF in 2026, Here's Where I'd Buy Invesco's NASDAQ 100 ETF is a great growth play for long-term investors.
Own VOO? Here's the Problem With Adding This Popular Growth ETF. Pairing VOO with QQQM gives you two top performers. But is it the best idea from a portfolio construction standpoint?
3 Cash-Producing Stocks That Fall Short While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
A Bearish-Dollar Options Surge Raises the Stakes for Warsh at Jackson Hole Call option volume in the Invesco DB U.S. Dollar Index Bearish Fund (UDN) surged roughly 1,144%, as traders weigh the Treasury's expanded bond buybacks against the Fed's Jackson Hole policy stance.
The Ultimate Growth ETF to Buy With $1,000 Right Now The Invesco Nasdaq 100 ETF has proven to be a consistent, reliable market outperformer.
How to Invest for an AI Boom, AI Bust, or...Both: These ETFs Can Help. It feels like we're reaching a moment of peak doubt about the AI boom, so investors have big choices to make.
The S&P 500's Biggest Stocks Keep Getting Bigger. Here's the ETF I'd Buy to Diversify The S&P 500 is historically top-heavy. Keep your large-cap exposure, but own the S&P 500 differently.
FHLC vs. PJP: Which Healthcare ETF Is the Better Buy for Investors? Here's how Invesco's concentrated pharma play compares to Fidelity's diversified approach to healthcare stocks.
Institutional Investors Are Buying Hyperliquid Strategies. Should You? There's a lot more to their purchasing than a desire to own Hyperliquid itself.
Which Consumer Staples ETF Is a Better Buy: Invesco's RSPS or SPDR's XLP? State Street's market-cap approach delivered 22% stronger 5-year gains, but Invesco's equal-weight strategy offers more balanced exposure.
The Smartest ETF to Buy With $750 Right Now The Invesco QQQ Trust has been a high-performing fund over the years.
Which Biotech ETF Is a Better Buy: Concentrated Bet or Broad Basket? VanEck's concentrated 25-stock approach offers higher individual company exposure, while Invesco's broader 251-position portfolio delivered 47.4% returns over the past year.
Which Aerospace & Defense ETF Is a Better Buy: Big Bets or Broad Exposure? ITA boasts lower costs and stronger 1-year returns, while PPA delivers broader diversification and superior 5-year growth.
Pharma ETF or Biotech ETF: Which Matches Your Investing Mindset? IHE delivered 53.2% returns over one year with lower volatility and a 0.37% expense ratio, while PBE's quantitative biotech strategy carries higher risk.
IBBQ vs. PBE: Which Biotech ETF Is the Better Buy? PBE concentrates on 31 companies and offers a higher dividend yield, while IBBQ spreads risk across 251 holdings at a fraction of the cost.
If We're in an AI Bubble, History Says This Is the Best Way to Recession-Proof Your Portfolio There might not be a safe place to hide in case of an AI bubble. But some ETFs could be less unsafe than others.
